What is the first line treatment for Methicillin-Sensitive Staphylococcus aureus (MSSA) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Methicillin-Sensitive Staphylococcus aureus (MSSA)

The first-line treatment for MSSA infections is a β-lactam antibiotic, specifically an anti-staphylococcal penicillin (such as oxacillin or nafcillin) or cefazolin. 1, 2

Preferred Agents for MSSA Infections

  • Intravenous options:

    • Oxacillin or nafcillin 2g IV every 6 hours 2
    • Cefazolin 0.5-1g IV every 8 hours 2
  • Oral options:

    • Dicloxacillin 125-250mg every 6 hours (dose depends on severity) 3
    • Cephalexin 500mg every 6 hours 2

Rationale for β-lactam Preference

  • β-lactam antibiotics demonstrate superior efficacy compared to vancomycin for MSSA infections 1, 4
  • Studies comparing nafcillin/oxacillin with cefazolin show similar clinical outcomes, making both excellent first-line choices 5
  • Penicillinase-resistant penicillins (flucloxacillin, dicloxacillin) remain the antibiotics of choice for serious MSSA infections 4

Treatment by Infection Type

Skin and Soft Tissue Infections

  • For minor skin infections: Dicloxacillin 125mg every 6 hours or cephalexin 500mg every 6 hours 2, 6
  • For moderate infections: Dicloxacillin 250mg every 6 hours 3
  • For abscesses: Incision and drainage plus empirical antibiotic coverage 2

Bacteremia and Serious Infections

  • For uncomplicated bacteremia: Oxacillin, nafcillin, or cefazolin for at least 2 weeks 1
  • For complicated bacteremia or endocarditis: 4-6 weeks of therapy 1
  • For pyomyositis: Cefazolin or antistaphylococcal penicillin (nafcillin or oxacillin) 2

Alternative Options for Penicillin-Allergic Patients

  • For non-immediate hypersensitivity: First-generation cephalosporins (cefazolin, cephalexin) 4
  • For immediate hypersensitivity (urticaria, angioedema, bronchospasm, anaphylaxis): Clindamycin or lincomycin 4
  • Note: Cephalosporins are contraindicated in patients with immediate penicillin hypersensitivity 4

Important Clinical Considerations

  • Blood cultures should be obtained before initiating therapy to confirm the causative organism 2
  • For serious infections, therapy should be continued for at least 14 days 3
  • Treatment should continue for at least 48 hours after the patient becomes afebrile, asymptomatic, and cultures are negative 3
  • Dicloxacillin is best absorbed when taken on an empty stomach (1 hour before or 2 hours after meals) 3

Common Pitfalls to Avoid

  • Using vancomycin for MSSA when β-lactams are available (vancomycin is less effective) 1, 2
  • Using broad-spectrum antibiotics like piperacillin/tazobactam as monotherapy for MSSA bacteremia (associated with higher mortality compared to nafcillin/oxacillin/cefazolin) 5
  • Inadequate duration of therapy, especially for complicated infections 3
  • Failure to obtain follow-up cultures in bacteremia to document clearance 1
  • Inadequate source control (drainage of abscesses, removal of infected devices) 1

By following these evidence-based recommendations, clinicians can optimize outcomes for patients with MSSA infections while practicing appropriate antimicrobial stewardship.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.